全文获取类型
收费全文 | 899篇 |
免费 | 66篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 27篇 |
妇产科学 | 26篇 |
基础医学 | 97篇 |
口腔科学 | 28篇 |
临床医学 | 168篇 |
内科学 | 217篇 |
皮肤病学 | 15篇 |
神经病学 | 34篇 |
特种医学 | 95篇 |
外科学 | 120篇 |
综合类 | 18篇 |
一般理论 | 4篇 |
预防医学 | 19篇 |
眼科学 | 9篇 |
药学 | 49篇 |
1篇 | |
肿瘤学 | 34篇 |
出版年
2021年 | 5篇 |
2020年 | 5篇 |
2019年 | 12篇 |
2018年 | 15篇 |
2017年 | 11篇 |
2016年 | 15篇 |
2015年 | 35篇 |
2014年 | 36篇 |
2013年 | 48篇 |
2012年 | 46篇 |
2011年 | 30篇 |
2010年 | 40篇 |
2009年 | 28篇 |
2008年 | 20篇 |
2007年 | 25篇 |
2006年 | 15篇 |
2005年 | 23篇 |
2004年 | 27篇 |
2003年 | 17篇 |
2002年 | 25篇 |
2001年 | 26篇 |
2000年 | 19篇 |
1999年 | 20篇 |
1998年 | 29篇 |
1997年 | 26篇 |
1996年 | 32篇 |
1995年 | 17篇 |
1994年 | 28篇 |
1993年 | 15篇 |
1992年 | 13篇 |
1991年 | 14篇 |
1990年 | 19篇 |
1989年 | 11篇 |
1988年 | 25篇 |
1987年 | 17篇 |
1986年 | 21篇 |
1985年 | 25篇 |
1984年 | 12篇 |
1983年 | 11篇 |
1981年 | 6篇 |
1980年 | 5篇 |
1979年 | 9篇 |
1977年 | 11篇 |
1976年 | 11篇 |
1975年 | 6篇 |
1973年 | 6篇 |
1972年 | 7篇 |
1969年 | 4篇 |
1968年 | 5篇 |
1967年 | 4篇 |
排序方式: 共有966条查询结果,搜索用时 156 毫秒
1.
J Flamm 《British journal of urology》1990,66(3):286-287
In patients under the age of 40 years with primary superficial bladder cancer the efficacy of adjuvant topical treatment was the same as in elderly patients (recurrences 23%, progression rate 8%). Patients should therefore be treated on the basis of stage and grade of the tumour regardless of their age. 相似文献
2.
Neuroophthalmologic abnormalities and intravascular therapy of traumatic carotid cavernous fistulas 总被引:1,自引:0,他引:1
Traumatic fistulas were successfully embolized using various transvascular approaches in 33 of 34 lesions. Complete superselective angiographic demonstration of the exact site of the shunt and possible collaterals was necessary to choose the appropriate embolization techniques. Improvement in the signs of orbital congestion was seen in all cases. Embolization, which directly occludes the fistula, precludes recurrences via collateralization and restores the normal arteriovenous gradient to the eye and optic nerve. 相似文献
3.
Golli M; Van Nhieu JT; Mathieu D; Zafrani ES; Cherqui D; Dhumeaux D; Vasile N; Rahmouni A 《Radiology》1994,190(3):741
4.
5.
6.
7.
8.
9.
Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage 总被引:3,自引:0,他引:3
E S Flamm H P Adams D W Beck R S Pinto J R Marler M D Walker J C Godersky C M Loftus J Biller D J Boarini 《Journal of neurosurgery》1988,68(3):393-400
A dose-escalation study of the calcium ion entry blocking drug nicardipine was performed using large dose infusions in 67 patients with recent aneurysmal subarachnoid hemorrhage (SAH). A safe, potentially therapeutic dose of the drug was determined. Patients admitted within 7 days of SAH from a documented cerebral aneurysm were entered into the study if no spasm was present on the initial angiogram. Nicardipine was administered as a continuous intravenous infusion throughout the 14-day period after SAH, regardless of the timing of surgery. To determine the safest possible dose, nicardipine was administered at seven dose levels from 0.01 to 0.15 mg/kg/hr. The total daily doses ranged from 27.7 mg to 375.0 mg. A follow-up angiogram was carried out on all 67 patients 7 to 10 days after SAH. Computerized tomography and neurological examinations were used to determine the presence of cerebral infarction. No major adverse effects, unexpected reactions, or permanent sequelae could be attributed to nicardipine. A decline in blood pressure was noted following administration of the drug. This occurred more frequently among patients given the largest dose but did not produce clinical problems or require discontinuation of the drug. Favorable outcomes were noted in 52 patients (78%). Vasospasm was found by arteriography in 31 patients (46%). A dose-related trend was noted: only eight (24%) of 33 patients treated at the highest dose level (approximately 10 mg/hr) developed arteriographic evidence of vasospasm. Symptomatic vasospasm was diagnosed in only two (6%) of 33 patients treated with this dose. Of the 34 patients receiving the lower dose levels, angiographic spasm was observed in 68% and symptomatic vasospasm in 27%. No deaths due to vasospasm occurred. Nicardipine appears to prevent both vasospasm and cerebral ischemia after SAH. A multicenter randomized double-blind trial to test this hypothesis is planned. 相似文献
10.
Inhibition of 2-nitropropane-induced rat liver DNA and RNA damage by benzyl selenocyanate 总被引:5,自引:2,他引:3
We observed that pretreatment of male F344 rats with benzyl selenocyanate,
a versatile organoselenium chemopreventive agent in several animal model
systems, decreases the levels of DNA and RNA modifications produced in the
liver by the hepatocarcinogen 2- nitropropane. To clarify the mechanisms
involved, we pretreated male F344 rats with either benzyl selenocyanate,
its sulfur analog benzyl thiocyanate, phenobarbital or cobalt
protoporphyrin IX; the latter is a depletor of P450. We then determined (1)
the ability of liver microsomes to denitrify 2-nitropropane, (2) effects on
2-nitropropane- induced liver DNA and RNA modifications and (3) amount of
nitrate excreted in rat urine following administration of the carcinogen.
Pretreatment with benzyl selenocyanate or phenobarbital increased the
denitrification activity of liver microsomes by 217 and 765%, respectively,
increased liver P4502B1 by 31- and 435-fold, respectively, decreased the
levels of 2-nitropropane-induced modifications in liver DNA (29-70% and
17-30%, respectively) and RNA (67-85% and 30-50%, respectively), and
increased the 24-h urinary excretion of nitrate by 157 and 209%,
respectively. Pretreatment with benzyl thiocyanate had no significant
effect on any of these parameters. Pretreatment with cobalt protoporphyrin
IX decreased liver P4502B 1 by 87%, decreased the denitrification activity
of liver microsomes by 76%, decreased the 24 h urinary excretion of nitrate
by 88.5%, but increased the extent of 2-nitropropane-induced liver nucleic
acid modifications by 17-67%. These results indicate that the metabolic
sequence from 2-nitropropane to the reactive species causing DNA and RNA
modifications does not involve the removal of the nitro group. Moreover,
they suggest that benzyl selenocyanate inhibits 2-NP-induced liver nucleic
acid modifications in part by increasing its detoxication through induction
of denitrification, although it is evident that other mechanisms must also
be involved.
相似文献